18506

0

SAROJA

img img img img
No Data Available

SAROJA PHARMA INDUS IND L Share Price Update

As of the latest trading session, SAROJA PHARMA INDUS IND L is trading at ₹33, up by ₹0.00 or 0.00% from its previous close. The stock has moved between ₹33.00 and ₹33.00 today. Over the past year, the stock has delivered a return of -13.15%. In the last month, it has returned 17.85%.

SAROJA PHARMA INDUS IND L performance

Today’s low Today’s high
₹ 33.00 ₹ 33.00
₹ 33.00
52 week low 52 week high
₹ 28.00 ₹ 60.00
₹ 33.00
Open Price ₹ 33.00
Prev. Close ₹ 33.00
Volume (Shares) 1600.00
Total traded value ₹ .52
Upper Circuit ₹ 34.65
Lower Circuit ₹ 31.35
info

Investment Returns

Over 1 Month 17.85% Over 3 Months -8.33% Over 6 Months -22.71% Over 1 Year -13.15%
demotext Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

SAROJA PHARMA INDUS IND L fundamentals


  • Market cap (Cr) 13.30
  • P/E Ratio (TTM) 12.84
  • Beta 1.17
  • Book Value / share 38.98
  • Return on equity 6.79%
  • EPS (TTM) 2.57
  • Dividend yield 0.00%
  • Net profit/quarter (Cr) 0.00
info icon alternate text
  • Market cap (Cr) [-]
  • P/E Ratio (TTM) [-]
  • Beta [-]
  • Book Value / share [-]
  • Return on equity [-]%
  • EPS (TTM) [-]
  • Dividend yield 0.00%
  • Net profit/quarter (Cr) [-]
info icon alternate text

SAROJA PHARMA INDUS IND L Financials

  • Key Results
  • Key Ratios
  • Balance sheet
  • Cash Flow
  • Competition
info-icon
Revenue
Net income
Particulars MAR 2025 (Values in Cr)
Revenue 53.73
Operating Expense 52.45
Net Profit 1.03
Net Profit Margin (%) 1.91
Earnings Per Share (EPS) 2.57
EBITDA 2.96
Effective Tax Rate (%) 28.27
Particulars MAR 2024 (Values in Cr)
Revenue 40.67
Operating Expense 39.66
Net Profit 0.88
Net Profit Margin (%) 2.16
Earnings Per Share (EPS) 2.49
EBITDA 2.75
Effective Tax Rate (%) 27.27
Particulars MAR 2023 (Values in Cr)
Revenue 50.19
Operating Expense 48.86
Net Profit 1.06
Net Profit Margin (%) 2.11
Earnings Per Share (EPS) 3.61
EBITDA 2.88
Effective Tax Rate (%) 28.85
Particulars MAR 2022 (Values in Cr)
Revenue 55.63
Operating Expense 54.37
Net Profit 1.14
Net Profit Margin (%) 2.04
Earnings Per Share (EPS) 50.49
EBITDA 2.42
Effective Tax Rate (%) 27.84
Particulars MAR 2021 (Values in Cr)
Revenue 36.66
Operating Expense 35.71
Net Profit 0.73
Net Profit Margin (%) 1.99
Earnings Per Share (EPS) 731.30
EBITDA 1.39
Effective Tax Rate (%) 28.84
Particulars MAR 2025 (Values in Cr)
Book Value / Share 38.99
ROE % 6.79
ROCE % 12.57
Total Debt to Total Equity 0.50
EBITDA Margin 5.53
Particulars MAR 2024 (Values in Cr)
Book Value / Share 36.42
ROE % 8.92
ROCE % 14.92
Total Debt to Total Equity 0.81
EBITDA Margin 6.76
Particulars MAR 2023 (Values in Cr)
Book Value / Share 17.33
ROE % 23.25
ROCE % 22.08
Total Debt to Total Equity 1.79
EBITDA Margin 5.74
Particulars MAR 2022 (Values in Cr)
Book Value / Share 178.30
ROE % 45.88
ROCE % 33.69
Total Debt to Total Equity 1.84
EBITDA Margin 4.35
Particulars MAR 2021 (Values in Cr)
Book Value / Share 935.90
ROE % 77.66
ROCE % 34.34
Total Debt to Total Equity 3.21
EBITDA Margin 3.79
Particulars MAR 2025 (Values in Cr)
Cash & Short Term Investments 0.33
Total Assets 39.55
Total Liabilities 39.55
Total Equity 15.67
Share Outstanding 0
Price to Book Ratio 0.97
Return on Assets (%) 2.61
Return on Capital (%) 4.12
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 0.32
Total Assets 26.56
Total Liabilities 26.56
Total Equity 14.64
Share Outstanding 0
Price to Book Ratio 0.96
Return on Assets (%) 3.30
Return on Capital (%) 4.31
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 0.36
Total Assets 21.33
Total Liabilities 21.33
Total Equity 5.08
Share Outstanding 0
Price to Book Ratio 0.00
Return on Assets (%) 4.97
Return on Capital (%) 6.94
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 0.26
Total Assets 15.51
Total Liabilities 15.51
Total Equity 4.02
Share Outstanding 0
Price to Book Ratio 0.00
Return on Assets (%) 7.34
Return on Capital (%) 11.22
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 0.00
Total Assets 8.22
Total Liabilities 8.22
Total Equity 0.93
Share Outstanding 0
Price to Book Ratio 0.00
Return on Assets (%) 8.89
Return on Capital (%) 18.5
Particulars MAR 2025 (Values in Cr)
Net Income 1.44
Cash from Operations 1.56
Cash from Investing -2.70
Cash from Financing 1.56
Net change in Cash 0.01
Free Cash Flow 1.67
Particulars MAR 2024 (Values in Cr)
Net Income 1.20
Cash from Operations 1.35
Cash from Investing -4.76
Cash from Financing 3.69
Net change in Cash -0.04
Free Cash Flow 1.74
Particulars MAR 2023 (Values in Cr)
Net Income 1.49
Cash from Operations 2.61
Cash from Investing -4.82
Cash from Financing 2.73
Net change in Cash 0.09
Free Cash Flow 6.34
Particulars MAR 2022 (Values in Cr)
Net Income 1.57
Cash from Operations -3.23
Cash from Investing -0.33
Cash from Financing 4.26
Net change in Cash 0.26
Free Cash Flow -2.93
Particulars MAR 2021 (Values in Cr)
Net Income 1.03
Cash from Operations -0.74
Cash from Investing -0.05
Cash from Financing 1.02
Net change in Cash -0.07
Free Cash Flow -0.69
Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
ATUL LTD. 7054.80 30.64 3.33 20770.57 5563.00 7793.00
BASF INDIA LTD 3584.80 37.28 3.92 15517.04 2906.90 5399.90
ORIENTAL AROMATICS LTD 309.60 315.92 1.56 1041.91 227.05 430.00
DEEPAK FERTILISERS & PETROCHEM 1384.15 19.97 2.68 17473.21 865.45 1776.95
DEEPAK NITRITE LTD. 1784.00 43.46 4.16 24332.52 1280.40 2135.00
Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
ADVANCE PETROCHEMICALS LTD. 305.45 0.00 7.39 27.49 97.60 320.75
ATUL LTD. 7054.80 34.91 3.42 20770.57 5563.00 7793.00
BASF INDIA LTD 3584.80 37.22 3.90 15517.04 2906.90 5399.90
ORIENTAL AROMATICS LTD 309.60 41.23 1.48 1041.91 227.05 430.00

SAROJA PHARMA INDUS IND L shareholding pattern

Holding
26.98%
73.01%
Name Shares Category
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)

SAROJA PHARMA INDUS IND L Technicals Summary

  • EMA & SMA
  • Resistance and Support
  • Delivery and Volume
  • Beta
  • Price Change Analysis
33.00 0.00 redarrow
red-green-graph indicator
0 Bearish
0 Bullish
  • 5 Days 0.00
  • 26 Days 0.00
  • 10 Days 0.00
  • 50 Days 0.00
  • 12 Days 0.00
  • 100 Days 0.00
  • 20 Days 0.00
  • 200 Days 0.00
33.00 PIVOT
First Support 33.00 First Resistance 33.00 Second Support 33.00 Second Resistance 33.00 Third Support 33.00 Third Resistance 33.00
RSI 50.46 ADX 31.93 MACD 0.00 Williams % R -28.57 Commodity Channel Index (CCI) 68.34
Date 2026-04-28 Week 4480.00 Same Day 1600.00 Month 4320.00
1 Year 1.17 3 Year 0.62
Over 1 Month
17.85% down
Over 1 Year
-13.15% down
Over 3 Months
-8.33% down
Over 3 Years
-21.51% down
Over 6 Months
-22.71% down
Over 5 Years
0.00% down

SAROJA PHARMA INDUS IND L Corporate Actions

Top Gainers

Top Losers

SAROJA PHARMA INDUS IND L Share Price

Saroja Pharma Industries India Limited was originally incorporated as Private Limited, in the name and style of 'Saroja Pharma Industries India Private Limited' on January 14 , 2019 vide Certificate of Incorporation issued by the Registrar of Companies, Mumbai, Maharashtra. Later on, Company was converted into Public Limited Company and due to conversion, name of the Company changed to 'Saroja Pharma Industries India Limited' dated April 18, 2023.

Saroja Pharma Industries India Limited was founded in 2019 by Mr. Biju Gopinathan Nair and Mr. Manish Dasharath Kamble, upon becoming a globally integrated and highly regarded pharmaceutical and healthcare company, the two Promoters embarked on a journey to establish their business.

In its initial stages, the Company operated as a Private Limited entity, operating with the name 'Saroja Pharma Industries India Private Limited.' During this time, they focused on building a strong foundation and laying the groundwork for their future growth and success. With dedication and strategic planning, they managed to establish a reputable presence in the pharmaceutical industry.

Gradually, as Company expanded and gained momentum, the Promoters made a significant decision to convert their business from a Private Limited to a Public Limited, through which the Company was establish. Thus, transformation opened up new avenues for growth, allowing it to access a wider pool of investors and enhance the overall market presence.

With the new status as a Public Limited Company, Saroja Pharma Industries India Limited further strengthen position into pharmaceutical and healthcare sectors. Thereafter, the Promoters envisioned leveraging the Company's expanded resources, increased capital formation, and enhanced market reach.

Since established, the Company provide service deliverance in chemical trading with the best premium pharmaceutical companies in India and abroad for cost effective human and veterinary medicine. Presently, the Company trade into Active Pharmaceuticals Ingredients (API), Pharma Intermediates, Specialty Chemicals, Intermediates for Pharma trading and Solvents used for pharmaceutical products in human and veterinary medicine.

Company launched the IPO by issuing 10,84,800 equity shares of Rs 10 each and raised a fresh issue of 9.11 crores on 5th September 2023.

In 2025, Company has increased demand for high value intermediates such as N-[(4S,6S)-6-Methyl-7,7-dioxido-2-sulfamoyl] and Para Nitro Phenol essential for drug synthesis. Growing concerns about antimicrobial resistance (AMR) have lead to tighter restrictions on the use of antibiotics in animals. The Company has expanded consumption demands in the emerging markets for their chain of manufacturing and supply chain networks.

Parent organization Indian Private
NSE symbol SAROJA
Founded 2019
stock
Trade stocks with ease

Sign-in to trade with your demat account, or set up a new demat account for free

Board Of Directors

Left Arrow
Right Arrow

Similar stocks

Left Arrow
Right Arrow

Frequently Asked Questions

What is the Current Share Price of Saroja Pharma Industries India Ltd?

Answer Field

Saroja Pharma Industries India Ltd share price is for NSE ₹ 33.00 & for BSE ₹ 0.00 as on Apr 28 2026 01:37 PM.

What is the Market Cap of Saroja Pharma Industries India Ltd Share?

Answer Field

The market cap of Saroja Pharma Industries India Ltd for NSE ₹ 13.30 & for BSE ₹ 0.00 as on Apr 28 2026 01:37 PM.

What is the 52 Week High and Low of Saroja Pharma Industries India Ltd?

Answer Field

The 52 Week High and Low of Saroja Pharma Industries India Ltd for NSE is ₹ 60.00 and ₹ 28.00 and for BSE is ₹ 0.00 and ₹ 0.00.

What is 1 year return for Saroja Pharma Industries India Ltd?

Answer Field

The 1 year returns on the stock has been -13.15%.

What is the P/E Ratio of Saroja Pharma Industries India Ltd Share?

Answer Field

As on Apr 28 2026 01:37 PM the price-to-earnings (PE) ratio for Saroja Pharma Industries India Ltd share is 12.84.

What is the PB ratio of Saroja Pharma Industries India Ltd Share?

Answer Field

As on Apr 28 2026 01:37 PM, the price-to-book (PB) ratio for Saroja Pharma Industries India Ltd share is 38.98.

How to Buy Saroja Pharma Industries India Ltd Share?

Answer Field

You can trade in Saroja Pharma Industries India Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Saroja Pharma Industries India Ltd Share on Bajaj Broking App?

Answer Field

To buy Saroja Pharma Industries India Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Saroja Pharma Industries India Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

close-image

Get Free Demat Account*

+91
close-img

Authorise with OTP

Enter the 4-Digit OTP sent to
edit
OTP expires in 00:59
banner-icon

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|

Please Enter Mobile Number

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|